Intergroup LEAP Trial (S1612): A Randomized Phase 2/3 Platform Trial to Test Novel Therapeutics in Medically Less Fit Older Adults with Acute Myeloid Leukemia

Source: American Journal of Hematology - Category: Hematology Authors: Tags: Correspondence Source Type: research